GENEVA, July 31 -- REMEDIUM BIO, INC. filed a patent application (US2026/012158) for “SEQUENCES FOR OPTIMAL PROCESSABILITY OF SECRETED THERAPEUTIC PROTEINS DELIVERED VIA VECTORS ADMINISTERED AS A SUBCUTANEOUS INJECTION”. With publication no. WO/2026/161566, here are the other details related to the patent application:
Kind: Initial Publication without ISR [A2]
IPC: C07K 14/47
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....